Medical Device Cybersecurity Importance

Updated December 27, 2025

Medical device cybersecurity isn’t a “nice-to-have.” It’s a patient safety issue, a product quality issue, and a trust issue-because modern MedTech doesn’t operate in isolation. Devices connect to networks, mobile apps, cloud services, hospital systems, and update infrastructure. When cybersecurity fails, the impact isn’t limited to data. It can affect availability, integrity, and essential performance-and that can disrupt care.

The good news is that cybersecurity doesn’t have to be overwhelming or purely technical. For medical device manufacturers, the goal is straightforward: reduce real-world risk and demonstrate the ability to manage it throughout the device lifecycle-from design to post-market.

Table of Contents

• Why cybersecurity matters in MedTech
• What is cybersecurity in the medical device industry?
• The appeal of medical device hacking
• The state of risk in the medical device industry
• What are the top cybersecurity issues in medical devices?
• FDA requirements and expectations for medical device cybersecurity (2025)
• SOUPs, SBOMs, and secure design patterns: their role in security (and better documentation)
• What manufacturers should actually do (and document)
• How experts can support cybersecurity in the medical device industry
• Bottom line
• Medical Device Cybersecurity FAQs

Why cybersecurity matters in MedTech

1) It protects patients and clinical operations

In healthcare, downtime and disruption can quickly become safety issues. A cybersecurity weakness can lead to loss of device availability, degraded performance, or unreliable data-forcing clinicians to delay decisions, switch workflows, or take devices out of service.

2) It protects product quality and brand trust

Customers don’t just buy features-they buy reliability. A cybersecurity incident can trigger emergency patches, customer escalations, field actions, reputational damage, and procurement headaches. Strong cybersecurity reduces those risks and makes your product easier to deploy and maintain.

3) It’s now a lifecycle expectation, not a premarket checkbox

Regulators and customers increasingly expect manufacturers to build security in, test it, document it clearly, and maintain it after launch. FDA’s most current cybersecurity guidance (updated in June 2025) reinforces this lifecycle mindset and focuses on evidence that a device is resilient to cybersecurity threats.

What is cybersecurity in the medical device industry?

Cybersecurity in the medical device industry describes the threats and risks related to how devices are built, connected, updated, and used in real clinical environments.

Most medical devices are connected for practical reasons, including:

• Remote patient monitoring (RPM) devices syncing readings from home to provider systems
• Implanted and therapy devices (e.g., pacemakers, infusion pumps) using wireless connectivity for monitoring or programming
• Diagnostic devices living on hospital networks and sharing images and patient data

On top of connectivity, devices include software and third-party components-meaning security depends on how well you manage updates, vulnerabilities, access control, and system interfaces over time.

The appeal of medical device hacking

Healthcare has always been a major target for attackers, and connected medical devices expand the threat landscape. Devices can be appealing because attackers may try to:

• Steal sensitive data (including ePHI)
• Launch ransomware to disrupt operations and create pressure to pay
• Target availability and safety to cause disruption or harm

The uncomfortable truth is that many cyber risks are preventable- but only if manufacturers design and maintain security as a product capability, not an afterthought.

The state of risk in the medical device industry

Real-world risk often shows up in familiar patterns: unpatched devices, outdated operating systems, weak identity and access management, and fragile update processes.

One example: the FBI has publicly warned about vulnerabilities from unpatched and outdated medical devices, highlighting how older software and missing security features can create attack opportunities and affect operations and patient safety.

You don’t need to be the “most hacked” company to feel the pain-one vulnerable product line, one exposed interface, or one slow patch cycle can create major downstream impact for customers.

What are the top cybersecurity issues in medical devices?

Medical devices are sophisticated hardware + software systems that connect to networks-so they often face risks similar to other IoT and software-enabled products. Common issues include:

• Lack of encryption (in transit or at rest)
• Weak or inconsistent authentication and authorization
• Outdated software that needs updates and patches
• Unsecured wireless communications
• Remote access vulnerabilities
• Integration challenges (device + app + cloud + hospital networks)
• Misconfigurations in device software, cloud services, or deployment environments

These are only a few. But the important point is this: you can’t fix what you can’t see, which is why threat modeling, testing, and SBOMs matter.

FDA requirements and expectations for medical device cybersecurity (2025)

Cybersecurity expectations for manufacturers are now clearer and more lifecycle-driven than they were just a few years ago.

A quick timeline manufacturers should know:

• March 29, 2023: Section 524B (“Ensuring Cybersecurity of Devices”) became effective (and generally doesn’t apply to submissions before that date).
• October 1, 2023: FDA’s “Refuse to Accept” posture became relevant for submissions missing required 524B cybersecurity information.
• June 2025: FDA updated its final premarket cybersecurity guidance (superseding the September 2023 version) and addressed recommendations related to Section 524B.

What Section 524B focuses on (plain English)

If your device is considered a “ cyber device” (software + internet connectivity + potential cybersecurity vulnerability), FDA expects cybersecurity information that supports lifecycle readiness. In practice, the most important expectations include:

• A plan for monitoring and addressing vulnerabilities postmarket (including coordinated vulnerability disclosure)
• Evidence you have processes to identify vulnerabilities and release patches/updates in a reasonable timeframe
• An SBOM (Software Bill of Materials) listing software components (including third-party and open-source)

In other words: cybersecurity isn’t just “what you built,” it’s also how you maintain it after launch.

Building or maintaining a cyber device?

Blue Goat Cyber is a medical-device-only cybersecurity firm. Our team runs the threat modeling, penetration testing, and FDA-facing documentation MedTech submissions live or die on. → Medical device penetration testing

SOUPs, SBOMs, and secure design patterns: their role in security (and better documentation)

Manufacturers also align to standards like IEC 62304 for software lifecycle processes. Three practical concepts help strengthen cybersecurity and reduce regulatory friction:

1) SOUP (Software of Unknown Provenance)

SOUP generally means third-party software you didn’t develop (commercial libraries, open-source packages, legacy components) where you don’t control the full development history. The cybersecurity reality: SOUP is often where vulnerabilities appear first.

What matters is not the label-it’s that you:

• identify third-party components,
• understand exposure in your configuration,
• track updates and vulnerabilities,
• document risk decisions and mitigations.

2) SBOM (Software Bill of Materials)

See also: When to Start Medical Device Cybersecurity, Medcrypt vs Finite State vs Blue Goat Cyber, and CVSS 3.1 vs 4.0 for Medical Devices.

An SBOM is an inventory of software components and dependencies used in your device ecosystem. The value isn’t the file-it’s what you can do with it:

• quickly determine if you’re affected by a new vulnerability,
• identify impacted versions,
• track remediation status,
• support postmarket monitoring and response.

3) Secure design patterns (including “facade” where appropriate)

Some teams use design patterns (like a facade) to simplify interfaces and reduce the chance that sensitive internal complexity is exposed through inconsistent access paths. This isn’t an FDA requirement-but it can be a helpful engineering technique when it supports:

• clearer interface boundaries,
• tighter control of authentication/authorization paths,
• reduced complexity in external-facing APIs.

Bottom line: standards and good engineering practices support security-but FDA reviewers care most about the traceable story and the evidence (risk → controls → tests → lifecycle plan).

What manufacturers should actually do (and document)

If you want cybersecurity to be repeatable (and not a constant fire drill), focus on the fundamentals below. These are also the same fundamentals that make FDA reviews smoother because your story becomes clear and traceable.

1) Threat model the full system (not just the device)

Threat modeling should reflect how your device is really used and connected:

• external interfaces (wired, wireless, remote access, APIs)
• trust boundaries
• likely attack paths
• clinical impact scenarios (availability, integrity, essential performance)

2) Turn threats into security requirements and controls

Don’t stop at “we use encryption.” Create:

• security requirements derived from threats and risk
• controls that implement those requirements
• traceability between them

3) Prove controls work with objective evidence

Strong evidence includes:

• a test plan tied to your threat model and requirements
• vulnerability testing with clear disposition
• penetration testing where appropriate
• remediation + retest evidence when fixes were required

4) Treat the SBOM like a living asset

Maintain SBOMs across releases and use them to drive vulnerability monitoring and response.

5) Have a real postmarket plan (not a paragraph)

A mature postmarket program includes:

• vulnerability intake and triage
• coordinated vulnerability disclosure (CVD)
• patch and mitigation planning
• customer communications and documentation

How experts can support cybersecurity in the medical device industry

Working with an experienced partner can reduce internal burden and improve speed-especially when you’re on a submission deadline.

Premarket submissions (510(k), De Novo, PMA)

A 510(k) submission demonstrates a device is safe and effective by showing substantial equivalence to a legally marketed predicate device. As cybersecurity expectations have grown, submissions often need clearer, more structured evidence-especially for connected devices.

Medical device penetration testing

Penetration testing simulates real-world attacks to uncover issues that automated scans often miss (logic flaws, interface weaknesses, access control gaps, unsafe update paths). It’s also a strong way to generate objective evidence that supports cybersecurity claims-especially when paired with remediation and retesting.

Bottom line

Cybersecurity in the medical device industry is about protecting patients, protecting clinical operations, and proving you can manage cybersecurity risk across the product lifecycle.

FDA review goes faster when your submission tells a simple, traceable story: threat model → security controls → testing evidence → SBOM → postmarket plan. When those pieces are complete and connected, you reduce follow-up questions, shorten review cycles, and lower the risk of last-minute rework.

If you want a second set of eyes before submitting, Blue Goat Cyber can review your current package and provide a prioritized gap list (what’s missing, what’s weak, and what to address first), so you can move forward with confidence.

Schedule a Discovery Session with us today.

How Blue Goat approaches this

Blue Goat Cyber applies a practical, risk-focused methodology to medical device cybersecurity. Our approach emphasizes integrating security into every phase of the product lifecycle, from initial design and development to post-market surveillance. We assist manufacturers with threat modeling, architecture reviews, penetration testing, and establishing efficient post-market vulnerability management programs. Our team, which includes individuals with CISSP and OSCP certifications, along with former military red team experience, focuses on actionable security improvements tailored to regulatory requirements. We identify gaps, help implement controls, and support documentation necessary for FDA submissions. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Learn more about our specialized threat modeling services at our Threat Modeling Services page.

FAQ

Why is cybersecurity important for medical devices?

Cybersecurity for medical devices is critical for patient safety, maintaining clinical operations, and Ensure product quality. Breaches can lead to device malfunction, data theft, and disruption of healthcare services.

What are common cybersecurity issues in medical devices?

Common issues include weak authentication, unencrypted data, outdated software, and vulnerabilities in remote access or wireless communication. These can be exploited if not properly addressed.

Does the FDA require cybersecurity for medical devices?

Yes, the FDA requires medical device manufacturers to address cybersecurity in premarket submissions for 'cyber devices' under Section 524B. The February 3, 2026 final guidance details these expectations.

What is an SBOM and why is it important?

An SBOM (Software Bill of Materials) is an inventory of all software components in a device. It helps manufacturers quickly identify if their devices are affected by new vulnerabilities and supports effective post-market response.

What is meant by medical device post-market cybersecurity?

Post-market cybersecurity involves ongoing processes after a device is released, such as monitoring for new vulnerabilities, issuing patches, and communicating with customers about security updates. It is a continuous effort.

How does threat modeling help medical device cybersecurity?

Threat modeling helps identify potential attack paths and vulnerabilities in a medical device and its ecosystem before development is complete. This proactive approach allows for security controls to be designed in from the start.

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.